Wenyue Zhang

4PUBLICATIONS
8CO-AUTHORS
Haematological tumoursPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 29, 2026
Lithocholic acid-activated VDR in macrophages promotes HCC recurrence post-ablation via SOCS3-mediated suppression of CXCL16.

|Feb 25, 2026
Machine Learning-Based Sialylation-Associated Gene Signature Predicts Prognosis and Immune Landscape in Hepatocellular Carcinoma: Validation via Multi-Omics Analysis and in vitro Assays.

Zijie Zheng, Yuening Wang, Wenyue Zhang

|Dec 02, 2025
Co-Delivery of Chemotherapy and Anti-Angiogenic Lipid via DPPA-LNPs Potentiates Anti-PD-1 Immunotherapy.

Jiabao Tan, Junyue Fang, Wanrong Luo

|Jul 27, 2023
Multifunctional Redox-Responsive Nanoplatform with Dual Activation of Macrophages and T Cells for Antitumor Immunotherapy.

Wenyue Zhang, Xiaodi Liu, Shuwen Cao

Pageof 1

Frequent Collaborators

1 joint publications

Junyue Fang

1 joint publications

Xiaoding Xu

1 joint publications

Phei Er Saw

1 joint publications

Rumei Li